The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity

A. Delieva, L. Dolinina, V. Trofimov (St. Petersburg, Russian Federation)

Source: Annual Congress 2013 –COPD: new markers of diseases
Session: COPD: new markers of diseases
Session type: Thematic Poster Session
Number: 600
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Delieva, L. Dolinina, V. Trofimov (St. Petersburg, Russian Federation). The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity. Eur Respir J 2013; 42: Suppl. 57, 600

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013

Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013



Increased serum level of apelin in chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: interesting notes
Year: 2015


Rosuvastatin influence on inflammatory and anti-inflammatory cytokines in blood in patients with chronic obstructive pulmonary disease
Source: International Congress 2017 – COPD management
Year: 2017


Interleukin-18 production and pulmonary function in COPD
Source: Eur Respir J 2008; 31: 287-297
Year: 2008



Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016

Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 551s
Year: 2006

Systemic inflammation in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Serum levels of leptin and visfatin in chronic obstructive pulmonary disease
Source: International Congress 2015 – Different data in COPD
Year: 2015


Levels of CC-chemokines (MCP-1, MIP-1α, MIP-1β) in induced sputum of patients with chronic obstructive pulmonary disease and patients with chronic bronchitis
Source: Eur Respir J 2001; 18: Suppl. 33, 194s
Year: 2001

Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006


Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: 325-331
Year: 2002



Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Local and systemic inflammation in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013


The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014


Potential association between pulmonary hypertension in COPD and monocyte chemoattractant protein (MCP)-1
Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology
Year: 2005


Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015


Biomarkers in the management of COPD
Source: Eur Respir Rev 2009; 18: 96-104
Year: 2009



Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015


COPD, an inflammatory systemic disease. Inflammatory parameters in a group of COPD patients
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014